CHE earnings

Full-Year Guidance Increased Due To: Strong VITAS PerformanceRe-purchase of 500,000 Shares in the QuarterTwo Roto-Rooter Franchises Purchased for $20.6 Million CINCINNATI, April 23, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2026, versus the comparable prior-year period. Results for Quarter Ended March 31, 2026 Consolidated operating results: Revenue increased 1.6% to $657.5 millionGAAP

CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2026, on Thursday, April 23, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, April 24, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/o65jro38. Participants may

CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results: Revenue was $639.3 million, essentially flat with the fourth quarter of 2024GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0%Adjusted Diluted EPS of $6.42, a decrease of 6.0% VITAS s

CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g. Part

CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2025, versus the comparable prior-year period. Results for Quarter Ended September 30, 2025 Consolidated operating results: Revenue increased 3.1% to $624.9 millionGAAP Diluted Earnings-per-Share (EPS) of $4.46, a decrease of 10.8%Adjusted Diluted EPS of $5.27, a decrease of 6.6% VITAS segment operating results: Net Pati

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 29, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/9m3ch5my. Participants may also register via teleconference a

  Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2025, versus the comparable prior-year period. Results for Quarter Ended June 30, 2025 Consolidated operating results: Revenue increased 3.8% to $618.8 million GAAP Diluted Earnings-per-Share (EPS) of $3.57, a decrease of 23.2% Adjusted Diluted EPS of $4.27, a decrease of 21.9% VITAS segment operating results: Net Patient Revenue of $396.2 milli

Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarter

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential qu

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2024, on Wednesday, February 26, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 27, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/pxs2dghv/. Participants may also register via teleconferen

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential quart

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2024, on Tuesday, October 29, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 30, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/c93ntfig/. Participants may also register via teleconference at:

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential quarte

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, July 25, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/unbdyk8k. Participants may also register via teleconference at: https:

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential quarte

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 25, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/as75yrfc. Participants may also register via teleconference at: http

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2023, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential qu

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2023, on Tuesday, February 27, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, February 28, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/586r6wmh. Participants may also register via teleconference

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2023, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted Diluted Earnings per Share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential qu

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2023, on Wednesday, October 25, 2023, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, October 26, 2023, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/9eyhbp68. Participants may also register via teleconference

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2023, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 4.2% to $554 million GAAP Diluted Earnings-per-Share (EPS) of $3.51 Adjusted Diluted EPS of $4.71, a decrease of 2.7% VITAS segment operating results: Net Patient Revenue of $321 million, an increase of 7.8% Average Daily Census (ADC) of 18,

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2023, on Wednesday, July 26, 2023, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, July 27, 2023, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ntafx2iw. Participants may also register via teleconference at: https:

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2023, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 5.6% to $560 million GAAP Diluted Earnings-per-Share (EPS) of $3.58 Adjusted Diluted EPS of $4.82, an increase of 0.6% VITAS segment operating results: Net Patient Revenue of $310 million, an increase of 3.8% Average Daily Census (ADC) of 17

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2023, on Wednesday, April 26, 2023, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 27, 2023, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/j92nc5np. Participants may also register via teleconference at: http

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2022, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 1.0% to $547 million GAAP Diluted Earnings-per-Share (EPS) of $4.13 Adjusted Diluted EPS of $5.39, an increase of 2.7% VITAS segment operating results: Net Patient Revenue of $308 million, a decline of 2.5% Average Daily Census (ADC) of 17,434,

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2022, on Thursday, February 23, 2023, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, February 24, 2023, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/rvyepdf9. Participants may also register via teleconference at:

  Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2022, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue declined 2.3% to $526 million GAAP Diluted Earnings-per-Share (EPS) of $3.78 Adjusted Diluted EPS of $4.74, a decline of 6.3% VITAS segment operating results: Net Patient Revenue of $297 million, a decline of 6.6% Average Daily Census (ADC) of 17,242,

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2022, on Monday, October 31, 2022, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Tuesday, November 1, 2022, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/8ovxyhbq. Participants may also register via teleconference at: htt

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2022, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue declined 0.2% to $531 million GAAP Diluted Earnings-per-Share (EPS) of $4.40, an increase of 25.4% Adjusted Diluted EPS of $4.84, an increase of 5.2% VITAS segment operating results: Net Patient Revenue of $298 million, a decline of 4.5% Average Daily Census

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2022, on Wednesday, July 27, 2022, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, July 28, 2022, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/z8752xj3. Participants may also register via teleconference at: https://r

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2022, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 0.6% to $531 million GAAP Diluted Earnings-per-Share (EPS) of $4.22, an increase of 5.2% Adjusted Diluted EPS of $4.79, an increase of 7.9% VITAS segment operating results: Net Patient Revenue of $299 million, a decline of 5.3% Average Daily Census

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, April 27, 2022, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants. The participant Conference ID is 1869526. A live webcast of the call can be accessed on Chemed's website at www.chemed.com by clicking on Inves

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 1.4% to $541 million GAAP Diluted Earnings-per-Share (EPS) of $4.81 Adjusted Diluted EPS of $5.25, an increase of 2.3% VITAS segment operating results: Net Patient Revenue of $316 million, a decline of 4.8% Average Daily Census (ADC) of 17,935,

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2021, on Thursday, February 24, 2022, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, February 25, 2022, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants. The participant Conference ID is 3267032. A live webcast of the call can be accessed on Chemed's website at www.chemed.com by clicking

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 2.0% to $539 million GAAP Diluted Earnings-per-Share (EPS) of $4.55, an increase of 9.9% Adjusted Diluted EPS of $5.06, an increase of 4.1% VITAS segment operating results: Net Patient Revenue of $317 million, a decline of 5.8% Average Daily Ce

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2021, on Thursday, October 28, 2021, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, October 29, 2021, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants. The participant Conference ID is 6082999. A live webcast of the call can be accessed on Chemed's website at www.chemed.com by clicking on

  Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 6.0% to $532 million GAAP Diluted Earnings-per-Share (EPS) of $3.51, a decrease of 29.9% Adjusted Diluted EPS of $4.60, an increase of 4.3% VITAS segment operating results: Net Patient Revenue of $312 million, a decline of 4.7% Average Daily Cen